(NASDAQ:KTWO) has seen its SMA20 which is now -17.81%. The average 1-year price target for (KTWO) reveals an average price target of $27.89 per share.
Several other brokerages have also recently weighed in on KTWO. A 11 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NASDAQ:KTWO) or, if they already own its stock, sell it. UBS initiated K2M Group Holdings Inc (NASDAQ:KTWO) on Tuesday, September 22 with "Buy" rating. The stock of K2M Group Holdings Inc (NASDAQ:KTWO) has "Market Outperform" rating given on Friday, April 8 by JMP Securities.
K2M Group Holdings, Inc. had its "outperform" rating reiterated by analysts at Cowen.
K2M Group Holdings, Inc. on 6/29/2017 reported its EPS as $-0.19 with the analysts projecting the EPS of the stock as $-0.3. The stock has "Buy" rating by Oppenheimer on Tuesday, July 11. There are brokerage firms with lower targets than the average, including one setting a price target of $26. About 956,392 shares traded or 59.00% up from the average. Given that its average daily volume over the 30 days has been 406.21K shares a day, this signifies a pretty significant change over the norm. K2M Group Holdings has a 52-week low of $16.32 and a 52-week high of $25.99.
The company is down by 20.43% at $17.33 and is one of the laggers in today's market.
The average 1-year price target for Cytori Therapeutics, Inc. The stock has "Buy" rating by Piper Jaffray on Wednesday, August 5. They expect this year's earnings to rise 6.38% year-over-year to $4.17, followed by 6.47% growth in the next year to $4.44. The business had revenue of $65.70 million for the quarter, compared to analysts' expectations of $66.26 million. K2M Group Holdings had a negative return on equity of 15.45% and a negative net margin of 16.21%. During the same quarter in the prior year, the firm earned ($0.27) EPS. K2M Group Hldngs Cmn (NASDAQ:KTWO)'s distance from 20 day simple moving average is-0.1569 along with distance from 50 day simple moving average of 22.1 whereas its distance from 200 day simple moving average is 22.53.
TRADEMARK VIOLATION WARNING: This story was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another publication, it was stolen and reposted in violation of USA and global copyright law. K2M Group Holdings's revenue for the quarter was up 11.0% on a year-over-year basis.
In related news, insider John Philip Md Kostuik sold 1,090 shares of the stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $23.37, for a total transaction of $919,773.09. The disclosure for this sale can be found here. Wells Fargo & Company MN now owns 63,322 shares of the medical device company's stock worth $1,542,000 after acquiring an additional 590 shares during the period. TimesSquare Capital Management LLC increased its position in shares of K2M Group Holdings by 31.5% during the second quarter.
Cytori Therapeutics (NASDAQ:CYTX)'s share price soared 3.74% or 0.02 to reach at $0.56 during previous trading session. The total value of its holdings increased 58.8%. American International Group Inc. grew its stake in shares of K2M Group Holdings by 7.1% during the 1st quarter. Schroder Investment Management Group increased its position in shares of K2M Group Holdings by 1.6% during the second quarter.
The share price of K2M Group Holdings, Inc. Vanguard Group Inc. now owns 1,550,592 shares of the medical device company's stock valued at $37,772,000 after buying an additional 171,502 shares in the last quarter. K2M Group Holdings earned a news sentiment score of 0.10 on Accern's scale.